PursueCare Blog - PursueCare

PursueCare Blog

April 17, 2020

COVID-19 and Substance Use Disorder

COVID-19 and Substance Use Disorder COVID-19 named by WHO for Novel coronavirus NCP concept. Doctor or lab technician holding blood sample with novel (new) coronavirus N.C.P. in Wuhan, Hubei Province, China, medical and healthcareAs coronavirus, or COVID-19, continues to spread there are parts of the population who run a higher […]
March 16, 2020

Staying Safe from Coronavirus (COVID-19)

Staying Safe from Coronavirus (COVID-19) The potential public health threat posed by COVID-19 is very high. U.S. state and federal health authorities are recommending that everyone prepare for the possibility of a coronavirus outbreak in their community. People with opioid use disorder (OUD), methamphetamine use disorder, and those who smoke […]
March 5, 2020
Coronavirus: How PursueCare Can Hel

Coronavirus: How PursueCare Can Help

Coronavirus: How PursueCare Can Help Coronavirus, or COVID-19, is a top concern for healthcare providers. The CDC predicts an inevitable spread of the virus throughout the United States. The Kentucky Department for Public Health held a statewide webinar for clinicians and public health on March 4th, recommending Infection Prevention and […]
October 4, 2019

What are Opioids & Opioid Addiction?

What are Opioids & Opioid Addiction? Opioids are a class of drugs that are commonly prescribed to treat pain. Opioids include both opiates (drugs derived from the opium poppy, including morphine, codeine, heroin, and opium) and synthetic opioids like hydrocodone, oxycodone, and methadone, which have similar effects.[1] Common prescription opioids include: […]
July 25, 2019

Reading The Play: How To Identify and Prevent Opioid Dependency In Athletes

Reading The Play: How To Identify and Prevent Opioid Dependency In Athletes It’s a story that is becoming more and more familiar in today’s society. A promising young athlete’s life is destroyed due to Opioid Use Disorder. It’s all too sad, and throughout the country many of us may directly […]
April 10, 2019

Opioids and the Brain

Opioids and the Brain Opioids are powerful drugs that act on the central nervous system in order to provide pain relief. The Drug Enforcement Administration (DEA) classifies most commercially available opioids as Schedule II controlled substances. This means that drugs such as morphine, fentanyl, oxycodone or hydromorphone are considered to […]
February 14, 2019

Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans

Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans By Dr. Jessica Badichek, PharmD A recent study published in JAMA, the Journal of the American Medical Association, summarized findings on the coverage of buprenorphine under Medicare Part D. Buprenorphine and buprenorphine combined with naloxone is one […]
January 29, 2019

FDA supports development of over-the-counter naloxone

  FDA supports development of over-the-counter naloxone By Dr. Jessica Badichek, PharmD A recent statement from FDA Commissioner Dr. Scott Gottlieb summarized the FDA’s new efforts in encouraging drug manufacturers to develop an over-the-counter version of naloxone, the opioid overdose treatment. The FDA stated that the number of overdose deaths […]
January 14, 2019

Drug Overdoses linked to Synthetic Opioids

  Drug Overdoses linked to Synthetic Opioids By Dr. Jessica Badichek, PharmD According to CDC analysis of the latest drug overdose death data, there were 63,632 drug overdose deaths in the United States in 2016. This was calculated as a 21.4% increase from 2015 data and the largest increase was […]
December 12, 2018
Woman sitting at laptop computer

Addiction Treatment & Telemedicine: An Update

  Addiction Treatment & Telemedicine: An Update By Dr. Jessica Badichek, PharmD The Centers for Medicare and Medicaid Services (CMS) recently published a report summarizing current evidence and practices in telemedicine-based services. This report discusses the substance abuse treatment barriers that persist throughout the country and how telemedicine also known […]